You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Moodys
Johnson and Johnson

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207707


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 207707 describes DOPAMINE HYDROCHLORIDE, which is a drug marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun, and is included in thirty-six NDAs. It is available from six suppliers. Additional details are available on the DOPAMINE HYDROCHLORIDE profile page.

The generic ingredient in DOPAMINE HYDROCHLORIDE is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
Summary for 207707
Tradename:DOPAMINE HYDROCHLORIDE
Applicant:Hikma Intl Pharms
Ingredient:dopamine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 207707
Medical Subject Heading (MeSH) Categories for 207707
Suppliers and Packaging for NDA: 207707
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 207707 ANDA West-Ward Pharmaceuticals Corp 0143-9252 0143-9252-25 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9252-25) > 5 mL in 1 VIAL, SINGLE-DOSE (0143-9252-01)
DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 207707 ANDA West-Ward Pharmaceuticals Corp 0143-9253 0143-9253-25 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9253-25) > 5 mL in 1 VIAL, SINGLE-DOSE (0143-9253-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength40MG/ML
Approval Date:Apr 11, 2018TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength80MG/ML
Approval Date:Apr 11, 2018TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Johnson and Johnson
McKinsey
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.